Edwards Larry Todd bought ARQT
January 12, 2024 · Form 4 insider transaction
Edwards Larry Todd bought 28,000 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,000
Price
$0.00
Total value
N/A
InsiderEdwards Larry Todd
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2024
Filing dateJanuary 17, 2024
Shares owned after88,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer.